WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock

$11.09+0.20 (+1.84%)
Updated Mar 27, 2024
FENC Price
$11.09
Fair Value Price
$0.04
Market Cap
$295.25M
52 Week Low
$6.30
52 Week High
$11.92
P/E
-14.59x
P/B
-28.04x
P/S
15.3x
PEG
N/A
Dividend Yield
N/A
Revenue
$13.05M
Earnings
-$20.22M
Gross Margin
94.9%
Operating Margin
-130.23%
Profit Margin
-154.9%
Debt to Equity
-2.81
Operating Cash Flow
-$19M
Beta
0.79
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

FENC Overview

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FENC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FENC ($11.09) is overvalued by 29,849.65% relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FENC ($11.09) is not significantly undervalued (29,849.65%) relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FENC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FENC due diligence checks available for Premium users.

Be the first to know about important FENC news, forecast changes, insider trades & much more!

FENC News

Valuation

FENC fair value

Fair Value of FENC stock based on Discounted Cash Flow (DCF)
Price
$11.09
Fair Value
$0.04
Overvalued by
29,863.16%
FENC ($11.09) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FENC ($11.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FENC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FENC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-14.59x
Industry
14.3x
Market
44.45x

FENC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-28.04x
Industry
6.2x

FENC's financial health

Profit margin

Revenue
$6.5M
Net Income
-$1.9M
Profit Margin
-28.7%
FENC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
FENC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$19.0M
Liabilities
$29.6M
Debt to equity
-2.81
FENC's short-term assets ($18.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FENC's long-term liabilities ($25.65M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FENC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FENC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.8M
Investing
$0.0
Financing
$201.0k
FENC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FENC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FENC$295.25M+1.79%-14.59x-28.04x
ATAI$297.16M+3.47%-4.16x1.12x
PSTX$297.19M+9.61%-2.25x2.87x
VSTM$298.99M+1.98%-2.98x5.21x
ACIU$300.57M+6.69%-4.17x1.65x

Fennec Pharmaceuticals Stock FAQ

What is Fennec Pharmaceuticals's quote symbol?

(NASDAQ: FENC) Fennec Pharmaceuticals trades on the NASDAQ under the ticker symbol FENC. Fennec Pharmaceuticals stock quotes can also be displayed as NASDAQ: FENC.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.

What is the 52 week high and low for Fennec Pharmaceuticals (NASDAQ: FENC)?

(NASDAQ: FENC) Fennec Pharmaceuticals's 52-week high was $11.92, and its 52-week low was $6.30. It is currently -7.01% from its 52-week high and 75.95% from its 52-week low.

How much is Fennec Pharmaceuticals stock worth today?

(NASDAQ: FENC) Fennec Pharmaceuticals currently has 26,634,676 outstanding shares. With Fennec Pharmaceuticals stock trading at $11.09 per share, the total value of Fennec Pharmaceuticals stock (market capitalization) is $295.25M.

Fennec Pharmaceuticals stock was originally listed at a price of $113.40 in Nov 12, 2004. If you had invested in Fennec Pharmaceuticals stock at $113.40, your return over the last 19 years would have been -90.22%, for an annualized return of -11.52% (not including any dividends or dividend reinvestments).

How much is Fennec Pharmaceuticals's stock price per share?

(NASDAQ: FENC) Fennec Pharmaceuticals stock price per share is $11.09 today (as of Mar 27, 2024).

What is Fennec Pharmaceuticals's Market Cap?

(NASDAQ: FENC) Fennec Pharmaceuticals's market cap is $295.25M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Fennec Pharmaceuticals's market cap is calculated by multiplying FENC's current stock price of $11.09 by FENC's total outstanding shares of 26,634,676.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.